 Zynerba Pharmaceuticals Inc NASDAQ:ZYNE Inc reported it has further expanded its intellectual property IP portfolio covering its Zygel CBD skin gel, with the award of an EU patent. The European patent office has now issued a patent entitled: Treatment of Fragile X Syndrome and Autism with Cannabidiol, the pharma group said in a brief statement. 